Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
NCT ID: NCT00457912
Last Updated: 2018-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
277 participants
OBSERVATIONAL
2005-06-30
2018-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)
NCT03981289
Genetic and Physical Study of Childhood Nerve and Muscle Disorders
NCT01568658
MRI and Muscle Involvement in Patients With Mutations in GMPPB
NCT02635321
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
NCT02450851
Phenotype/Genotype Correlations in Neuromuscular Disorders
NCT00017745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must visit Columbus Children's Hospital for 2-day study visit
* muscle biopsy tissue must be available; either from previous biopsy, affected relative, or willing to have biopsy at Columbus Children's
Exclusion Criteria
* unable to provide muscle tissue from previous or current biopsy
* incapable of giving consent and not having a legal guardian willing or able to do so
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Muscular Dystrophy Association
OTHER
Nationwide Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jerry R. Mendell
DIRECTOR CENTER FOR GENE THERAPY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jerry R. Mendell, M.D.
Role: PRINCIPAL_INVESTIGATOR
The Research Institute at Nationwide Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nationwide Children's Hospital
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH Grant U54AR050733
Identifier Type: -
Identifier Source: secondary_id
IRB05-00101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.